Stock Earnings

Question 1

aTyr Pharma Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, aTyr Pharma Inc'in toplam varlıkları $96 olup, net loss $-64'dir.

Question 2

ATYR'ün temel finansal oranları nelerdir?

Accepted Answer

aTyr Pharma Inc'in cari oranı 3.69, net kâr marjı 0, hisse başına satış $0'dir.

Question 3

aTyr Pharma Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

aTyr Pharma Inc largest revenue segment is Innovative Medicines, at a revenue of 235,000 in the most earnings release.For geography, United States is the primary market for aTyr Pharma Inc, at a revenue of 235,000.

Question 4

aTyr Pharma Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre aTyr Pharma Inc'in net loss $-64'dir.

Question 5

aTyr Pharma Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, aTyr Pharma Inc'in yükümlülüğü 26'dir.

Question 6

aTyr Pharma Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

aTyr Pharma Inc'in toplam tedavüldeki hisse sayısı 84.03'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	10	0	10
Revenue Growth (YoY)	--	--	-100%	--	-100%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	17	13	12	13	10	9
Research & Development	61	54	42	42	23	17
Operating Expenses	78	68	55	56	34	26
Other Non Operating Income (Expenses)	3	3	4	1	0	0
Pretax Income	-75	-64	-50	-45	-33	-16
Income Tax Expense	--	--	--	--	--	--
Net Income	-75	-64	-50	-45	-33	-16
Net Income Growth	19%	28%	11%	36%	106%	-30%
Shares Outstanding (Diluted)	97.15	74.26	53.6	28.42	19.08	9.16
Shares Change (YoY)	28%	39%	89%	49%	108%	173%
EPS (Diluted)	-0.77	-0.86	-0.94	-1.6	-1.77	-1.77
EPS Growth	-8%	-8%	-41%	-10%	0%	-75%
Free Cash Flow	-62	-69	-37	-43	-33	-15
Free Cash Flow Per Share	-0.63	-0.92	-0.69	-1.51	-1.72	-1.63
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	-459.99%	0%	-150%
Profit Margin	0%	0%	0%	-450%	0%	-160%
Free Cash Flow Margin	0%	0%	0%	-430%	0%	-150%
EBITDA	-78	-67	-54	-46	-34	-15
EBITDA Margin	0%	0%	0%	-459.99%	0%	-150%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-78	-67	-54	-46	-34	-15
EBIT Margin	0%	0%	0%	-459.99%	0%	-150%
Effective Tax Rate	--	--	--	--	--	--

aTyr Pharma Inc (ATYR) Price

ATYR Stock Price Chart

ATYR Income

Follow-Up Questions